by Aline Fieck | Dec 1, 2025 | Featured
Qynapse participated alongside Paris Santé Campus at the Adopt AI congress in Paris, highlighting its commitment to advancing AI-driven innovations in neuroscience and digital...
by Aline Fieck | Dec 1, 2025 | Featured, News, Updates
PARIS, FRANCE, December 1, 2025 – Qynapse is present at CTAD Clinical Trials on Alzheimer’s Disease 2025 in San Diego. Meet Olivier Courrèges and Michael Tunkelrott and discover how Qynapse’s clinically validated AI solutions are advancing Alzheimer’s disease...
by Aline Fieck | Oct 1, 2025 | Uncategorized
Qynapse Alzheimer’s disease – Brochure QyScore® Brochure QyScore®...
by Aline Fieck | Jul 27, 2025 | Featured, News
Toronto, Canada – July 28, 2025 – Qynapse, a technology company using AI to enhance the quantification and predictive capabilities of imaging to improve outcomes for neurological diseases, including Alzheimer’s disease (AD), presented new data at the Alzheimer’s...
by Aline Fieck | Jul 22, 2025 | Uncategorized
Qynapse Alzheimer’s disease – Brochure Comparison of automated segmentation pipelines – Poster MRI-based predictive models. Treatment prioritization & clinical trial – Poster Qynapse Press Release July 28, 2025 QyScore...
